Express Scripts, PCMA sue to block Tennessee law breaking up PBMs and pharmacies - Healthcare Dive
Tennessee law aimed at breaking up PBMs and pharmacies is being challenged in court, potentially delaying its implementation and affecting pharmacy operations.
Aforeworn detected this change in the Pharmaceutical Manufacturing (FDA/DEA) space on August 22, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Pharmacies and pharmacy benefit managers (PBMs) operating in Tennessee. should confirm how it applies to their specific situation before acting. There is a time constraint attached: No specific deadline stated; ongoing legal proceedings.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmaceutical Manufacturing (FDA/DEA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Legal action against the Tennessee law that seeks to separate PBMs from pharmacies, which may impact operational structures and relationships.
Who it affects
Pharmacies and pharmacy benefit managers (PBMs) operating in Tennessee.
What you must do
Monitor the legal proceedings and prepare for potential changes in operations depending on the outcome.
Deadline
No specific deadline stated; ongoing legal proceedings.
Never miss a change like this again
Aforeworn watches Pharmaceutical Manufacturing (FDA/DEA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmaceutical Manufacturing (FDA/DEA)
- Evaluation of Therapeutic Equivalence; Guidance for Industry; Availability
- Food and Drug Administration Modernization Act of 1997: Modifications to the List of Recognized Standards, Recognition List Number: 066
- 10 pharma execs charged with illegally selling 70M Opioid Pill - fda.gov
- Marijuana Rescheduling in Jeopardy? A Federal Court is About to Decide Whether the Attorney General Acted Improperly - newswire.com
- Lupin Receives EIR from U.S. FDA for its Somerset Manufacturing Facility - Lupin | Press Release - lupin.com